ZYNE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (11 Oct 2023 @ 04:00):

Stats
今日成交量	861 742
平均成交量	1.04M
市值	70.12M
EPS	$0 ( 2024-03-26 )
下一个收益日期	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.646
ATR14	$0.0400 (3.08%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-10	Jones Kenneth T	Buy	30 000	Common Stock
2023-10-10	Jones Kenneth T	Sell	40 520	Common Stock
2023-10-10	Jones Kenneth T	Sell	75 000	Common Stock
2023-10-10	Jones Kenneth T	Sell	21 250	Stock Option (Right to Buy)
2023-10-10	Stephenson Pamela	Sell	27 954	Common Stock

INSIDER POWER
-52.80
Last 100 transactions
Buy: 1 916 312 \| Sell: 5 402 740

音量相关性

長: 0.26 (neutral)

短: -0.55 (weak negative)

Signal:(58.623) Neutral

Zynerba Pharmaceuticals 相关性

10 最正相关
FULT	0.896
BUSE	0.856
CBSH	0.852
GOODM	0.85
CMCT	0.847
CCNE	0.847
COLB	0.847
FBIZ	0.844
AMTB	0.841
INTZ	0.839

10 最负相关
AMRB	-0.841
LMRKN	-0.834
LWAC	-0.817
RAVN	-0.811
SRAC	-0.811
CALT	-0.809
OBT	-0.809
LONE	-0.806

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Zynerba Pharmaceuticals 相关性 - 货币/商品

0.23
( neutral )

0.48
( neutral )

0.77
( moderate )

0.67
( moderate )

-0.31
( neutral )

Zynerba Pharmaceuticals 财务报表

Annual	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.820

FY	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.820

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.950

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.900

Financial Reports:

No articles found.

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.